http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Jun 2026 06:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Press+Releases/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html <p align="justify">VIRGINIA CITY, Nev., June 22, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced that it has executed a Securities Purchase Agreement (the “SPA”) to sell 100% of its mineral, mining, processing and related mining district real estate entities to Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold &amp; Silver Corp., for an aggregate transaction value of over $45 million, consisting of over $30 million in cash and stock payments, a retained 1.5% NSR royalty, the assumption of all reclamation obligations and liabilities, and an additional contingent http://www.streetinsider.com/Globe+Newswire/Comstock+Sells+Legacy+Mining+Assets+to+Mackay+Precious+Metals+Inc./26669464.html Mon, 22 Jun 2026 06:15:00 -0400 LODE MACK MKGSF O.01671474 O.47556286 http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++MERRIMACK+PHARMACEUTICAL+++++++++++++/23252226.html si-local-file:///var/storage/secattach/20240520/23252226.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++MERRIMACK+PHARMACEUTICAL+++++++++++++/23252226.html Mon, 20 May 2024 16:06:00 -0400 MACK O.00647906 http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++MERRIMACK+PHARMACEUTICAL+++++++++++++/23252226.html si-local-file:///var/storage/secattach/20240520/23252226.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++MERRIMACK+PHARMACEUTICAL+++++++++++++/23252226.html Mon, 20 May 2024 16:06:00 -0400 MACK O.00647906 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MERRIMACK+PHARMACEUTICAL++For%3A+Mar+31/23234025.html si-local-file:///var/storage/secattach/20240515/23234025.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MERRIMACK+PHARMACEUTICAL++For%3A+Mar+31/23234025.html Wed, 15 May 2024 16:30:00 -0400 MACK O.00647906 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MERRIMACK+PHARMACEUTICAL++For%3A+Mar+31/23234025.html si-local-file:///var/storage/secattach/20240515/23234025.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MERRIMACK+PHARMACEUTICAL++For%3A+Mar+31/23234025.html Wed, 15 May 2024 16:30:00 -0400 MACK O.00647906 http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/Press+Releases/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/ACCESS+Newswire/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/ACCESS+Newswire/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/ACCESS+Newswire/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/ACCESS+Newswire/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT http://www.streetinsider.com/ACCESS+Newswire/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html <p><strong>STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 /</strong> Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier, MD, PhD and Yasir Al-Wakeel BM, BCh.</p><p>Hans Schikan has been a member of the Board since 2018 and is a http://www.streetinsider.com/ACCESS+Newswire/Vicore+Expands+and+Strengthens+its+Board+of+Directors/23218417.html Tue, 14 May 2024 02:20:00 -0400 KRON MACK MXCT NTGN PHVS RNA TBIO VECT